---
source:
  family: "GUIDANCE"
  instrument: "FDA Guidance"
  title: "Policy on Warning Label Required on Sunlamp Products"
  docket: "FDA-2020-D-0957"
  path: "523_Policy_on_Warning_Label_Required_on_Sunlamp_Products.pdf"
  pages: 2
  converted: 2026-02-27
  method: pdftotext
---

Public Health Service
-

-

Food and Drug Adm~n~stration
8 7 5 7 Georgia Avenue
Silver Spring MD 2091 0

TO: ALL MANUFACTURERS, IMPORTERS AND POTESJTIAL MANUFACTURERS

OF SUNLAMP PRODUCTS.
SUBJECT: POLICY ON WARNING LABEL REQUIRED ON SUNLAMP PRODUCTS.
BACKGROUND:

The Center f o r Devices and Radiological Health has f o b d numerous inported
and dcmestic sunlamp products labeled i n such a way a s t o render t h e l a b e l
i l l e g i b l e and/or inaccessible t o view by t h e consumer under normal
conditions of purchase and use.
Sunlamp products a r e e l e c t r o n i c products a s defined by Section 355(2)
[42 U.S,C 263c(2)1 of t h e Radiation Control f o r Health and Safety A c t
of 1968 (RCHSA) and medical devices a s defined by Section 201(h)(3) of t h e
The
Federal Food, Drug, and Cosmetic Act (FD&C) [21 U.S.C.321(h)(3)1.
performance standard f o r sunlamp products (21 CFR 1040.20) promulgated
under a u t h o r i t y of Section 358 of t h e RCHSA, requires t h a t l a b e l s
containing s p e c i f i c information be permanently a f f i x e d o r inscribed on an
e x t e r i o r s u r f a c e of t h e product s o a s t o be l e g i b l e and readily accessible
t o view when t h e product is f u l l y assembled f o r use. The general labeling
provisions f o r medical devices under 21 CFR 801.5 require adequate
d i r e c t i o n s f o r use be provided t o t h e u s e r and 21 CFR 801.15 defines t h e
praninence of t h e required l a b e l statements f o r devices.
POLICY:
The intended purpose of t h e warning l a b e l required on sunlanp products is
t o provide t h a t information necessary f o r t h e consumer t o make an informed
decision regarding t h e r i s k s of using sunlamp products and t o provide
adequate d i r e c t i o n s f o r s k i n tanning. Therefore, t h e l a b e l must be l e g i b l e
and conspicuously placed on t h e product so a s t o render it l i k e l y t o be
read by t h e user under nonnal conditions of purchase and use. The Agency
w i l l consider sunlarnp products t o be nonccanpliant with t h e performance
standard under Section 3 5 8 ( a ) ( 1 ) of t h e RCHSA and misbranded under Section
502(c) of t h e FD&C A c t i f t h e required product l a b e l is not l e g i b l e and
accessible t o view f o r t h e following reasons:

Page 2
1. The l a b e l required under 21 CFR 1040.20(d)(l) does not appear on a
praminent p a r t or panel which is presented o r displayed under normal
conditions of purchase and/or use.

2. Adequate space is not provided f o r t h e required l a b e l o r t h e
l a b e l is not p r m i n e n t l y displayed on t h e device.
3. The normal individual can not read t h e l a b e l from a distance
of one meter because of inadequate l e t t e r i n g s i z e and background
c o n t r a s t . Lettering of t e n (10) millimeters (height) f o r t h e word
"I;\ANGERW and f i v e ( 5 ) millimeters f o r t h e rest of t h e l a b e l information
is recamended t o meet t h e v i s i b i l i t y requirements.

rcl&&

Wa ter
Gundaker. Director
Off ice of compliance
Center f o r &vices
and Radiological Health


